Philip Morris
Suspension of Dow Purchases
Fields
- Author
- Latshaw, R.D.
- Type
- MEMO, MEMORANDUM
- Document File
- 2023799679/2023799822/Operations 940000 - 860000
- Area
- PM USA/CARLSTADT
- Request
- Stmn/R1-004
- Stmn/R1-071
- Copied
- Morgan, L.W.
- Adkins, G.C.
- Harris, W.B.
- Named Organization
- Dow Chemical
- Merrell
- Smoking Cessation Newsletter
- Site
- N308
- Named Person
- Morgan, L.W.
- Bujold, J.
- Butler, A.
- Harris, W.B.
- Ihrig, R.
- Latshaw, R.D.
- Master ID
- 2023799789/9807
- 2023799789 Dow Nicorette
- 2023799790
- 2023799791
- 2023799792
- 2023799793-9794 If You Want to Quit for Good... Your Doctor Can Help
- 2023799795 Dow Nicorette
- 2023799796-9797 Dow - Nicorette Situation
- 2023799798 Merrell Dow Pharmaceutical Meeting - 820713
- 2023799801-9802 Dow - Nicorette Meeting, 841023
- 2023799803 000118 Conference Call with Andrew Butler, Dow Chemical, A.J. Kay, Jr., R. D. Lathaw
- 2023799804
- 2023799805
- 2023799806
- 2023799807 If You Want to Quit Smoking for Good, See Your Doctor
Related Documents:
Document Images
PHILIP MORRIS U. S. A.
INTER-OFFICE CORRESPQNDENCE
RICHNOMD. YIRBiMIA
To: . Mr. A. J. Kay, Jr.
From: . R. D. Latshaw
subj.ct: . SUSPENSION OF DOW PURCHASES
Dat.: May 7, 1984
Per our conversations, we ceased issuing glycerine, propylene glycol,
and triethylene glycol orders to Dow. They requested a meeting to
discuss the situation which was held on Wednesday, May 2. Dow
attendees were Ron Ihrig, District Manager; Joe Bujold, Corporate
Accounts Manager; and Tony Butler, Sales Representative. Representing
Philip Morris were L. W. Morgan, W. B. Harris, and R. D. Latshaw.
Dow was told that we were discontinuing all humectant purchases because
of Dow-Merrell's attack on cigarette smoking associated with the intro-
duction of Nicorette, a nicotine-containing prescription chewing gum
which reportedly aids "patients" in quitting smoking. Specific examples
of Dow's objectionable campaign were cited:
1.. Efforts to encourage all smokers at their Freeport Plant
(source of most of our materials) to give up cigarettes.
2. The Dow sponsored Policy Analysis Incorporated study indicating
an additional $59,000 lifetime medical expense for smokers.
3. Dow literature appearing in doctors' offices encouraging smokers
to quit- by using Nicorette.
4. A new Richmond doctors' clinic discouraging smoking and offering
Nicorette.
Through a series of meetings over the past few years, Dow had been repeat-
edly advised of our displeasure over the anti-smoking nature of Dow-
Merrell's Nicorette program. We had been assured that Nicorette would
have a low-key introduction and would be aimed only at those smokers who
had to stop for medical reasons. Dow continually insisted that they were
not taking an anti-cigarette industry position, and backed that assertion
two years ago by withdrawing the Smoking Cessation Newsletter. (This
document was circulated to physicians and contained much anti-smoking
propaganda. Only one issue was printed.)
Dow was informed that the recent spate of activity can only be interpreted
as a conscious corporate decision that Nicorette is more important than the
Philip Morris (and other tobacco) business. That is, they cannot realisti-
cally expect a customer to spend millions of dollars for materials, when
the profits from those sales, directly or indirectly, are used to attack
that customer's product and perhaps reduce the customer's sales.
2023'799799

Mr. A. J. Kay, Jr. - 2 - May 7, 1984
The Dow representatives (who organizationally have no relationship to
Dow-Merrell) repeated their previously made claim that Dow was not trying
to assault the cigarette industry. However, they could not refute the
evidence and were told that we could not deal with intent, but could only
assess the documentation in hand which strongly indicates that Dow
Chemical is engaged in a program to motivate Philip Morris customers to
stop smoking.
We indicated that the suspension of business was regrettable since Dow
had been a top-notch supplier over the past ten years. Dow responded by
saying Philip Morris would remain a priority customer should we desire to
purchase materials in the future.
Bujold and Ihrig are planning to visit Dow's headquarters in Midland,
Michigan to review the situation with corporate management.
RDL/lwk
cc: G. C. Adkins
W. B. Harris
L. W. Morgan
